Ratiopharm

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Ratiopharm
Type Private
Industry Pharmaceutical industry
Founded 1974
Headquarters Ulm, Germany
Key people Adolf Merckle, founder
Oliver Windholz, CEO
Products Pharmaceuticals and generic medication.
Revenue Increase 1.8 billion (2007)
Employees 5,417 (2007)
Website Ratiopharm.com
12-08-18-tilidin-retard.jpg

Ratiopharm is a German pharmaceutical company that is Europe's leading generics brand.

Ratiopharm was owned by Adolf Merckle and makes generic Pharmaceuticals. They are based in Ulm, Germany and products being distributed in over 35 countries worldwide.

On March 18, 2010, Teva announced that it planned to acquire Ratiopharm for US$5 billion.[1][2] On August 10, 2010, Teva announced that it had completed its acquisition of Ratiopharm.[3]

See also[edit]

References[edit]

  1. ^ NATASHA SINGER (March 18, 2010). "Teva to Acquire Top German Generics Maker for $5 Billion". The New York Times. Retrieved March 18, 2010. 
  2. ^ Teva to Acquire Generics Firm The Wall Street Journal March 19, 2010
  3. ^ "Teva Completes Acquisition of Ratiopharm". August 10, 2010. Retrieved August 20, 2010. 

External links[edit]